Concepedia

D. A. Singh

DA

9

Publications

1K

Citations

9

H-Index

2004

Active since

Affiliations

University of Chicago(Current)

University of Southern California

City Of Hope National Medical Center

University of California, Davis

UPMC Hillman Cancer Center

D. A. Singh is an author at University of Chicago specializing in oncology, cancer research, and medicine.

Top concepts

Publications per year

2004–2009

9

Publications

9

Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer

Hedy L. Kindler, Gregory Friberg, D. A. Singh et al. · Journal of Clinical Oncology · 2005 · 458 citations · Full text

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

Ramesh K. Ramanathan, Chandra P. Belani, D. A. Singh et al. · Cancer Chemotherapy and Pharmacology · 2009 · 286 citations

, , +9

Multicenter Phase II Trial of S-1 Plus Cisplatin in Patients With Untreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Jaffer A. Ajani, Fa-Chyi Lee, D. A. Singh et al. · Journal of Clinical Oncology · 2006 · 92 citations · Full text

Phase II study of lapatinib, a dual inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase 1 and 2 (Her2/Neu) in patients (pts) with advanced biliary tree cancer (BTC) or hepatocellular cancer (HCC). A California Consortium (CCC-P) Trial

Ramesh K. Ramanathan, Chandra P. Belani, D. A. Singh et al. · Journal of Clinical Oncology · 2006 · 64 citations

, , +16

A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours

Samir D. Undevia, Federico Innocenti, Jacqueline Ramı́rez et al. · European Journal of Cancer · 2008 · 62 citations · Full text

, , +8

Rows per page

1–5 of 9